Australia markets closed

Teva Pharmaceutical Industries Limited (TEVJF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
8.00-1.00 (-11.11%)
At close: 10:05AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.91B
Enterprise value 29.31B
Trailing P/E 900.00
Forward P/E 3.08
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.57
Price/book (mrq)0.98
Enterprise value/revenue 1.90
Enterprise value/EBITDA 145.80

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 3-8.78%
S&P500 52-week change 3-16.88%
52-week high 311.95
52-week low 37.00
50-day moving average 39.21
200-day moving average 38.57

Share statistics

Avg vol (3-month) 3488
Avg vol (10-day) 310
Shares outstanding 51.11B
Implied shares outstanding 6N/A
Float 81.1B
% held by insiders 10.78%
% held by institutions 14.18%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 427 Nov 2017
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022


Profit margin -6.83%
Operating margin (ttm)18.87%

Management effectiveness

Return on assets (ttm)3.83%
Return on equity (ttm)-10.03%

Income statement

Revenue (ttm)15.43B
Revenue per share (ttm)13.95
Quarterly revenue growth (yoy)-3.20%
Gross profit (ttm)7.59B
Net income avi to common (ttm)-1.05B
Diluted EPS (ttm)-0.56
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.06B
Total cash per share (mrq)1.85
Total debt (mrq)22.45B
Total debt/equity (mrq)228.46
Current ratio (mrq)1.11
Book value per share (mrq)8.14

Cash flow statement

Operating cash flow (ttm)1.06B
Levered free cash flow (ttm)2.54B